LUMO - Lumos Pharma's (LUMO) CEO Rick Hawkins on Q4 2020 Results - Earnings Call Transcript

Lumos Pharma, Inc. (LUMO) Q4 2020 Earnings Conference Call March 9, 2021 4:30 PM ET Company Participants Lisa Miller – Director-Investor Relations Rick Hawkins – Chief Executive Officer, President and Chairman John McKew – Chief Operating Officer and Chief Scientific Officer Gene Kennedy – Chief Medical Officer Carl Langren – Chief Financial Officer Conference Call Participants Charles Duncan – Cantor Fitzgerald Ed White – H.C. Wainwright Lina Kaminski – JonesTrading Yasmeen Rahimi – Piper Sandler Elemer Piros – Roth Capital Partners Presentation Operator Good afternoon, ladies and gentlemen, and welcome to the Lumos Pharma's Year-End 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Director of Investor Relations. Ms. Miller, please go

For further details see:

Lumos Pharma's (LUMO) CEO Rick Hawkins on Q4 2020 Results - Earnings Call Transcript